Blood circulating microparticle species in relapsing–remitting and secondary progressive multiple sclerosis. A case–control, cross sectional study with conventional MRI and advanced iron content imaging outcomes

Nylander, 2012, Multiple sclerosis, J. Clin. Invest., 122, 1180, 10.1172/JCI58649 Prosperini, 2012, Predictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosis, J. Neurol. Sci., 323, 104, 10.1016/j.jns.2012.08.027 Wee, 2010, Inflammation in neurological disorders: a help or a hindrance?, Neuroscientist, 16, 408, 10.1177/1073858410371379 Minagar, 2001, Elevated plasma endothelial microparticles in multiple sclerosis, Neurology, 56, 1319, 10.1212/WNL.56.10.1319 Steinman, 2012, Platelets provide a bounty of potential targets for therapy in multiple sclerosis, Circ. Res., 110, 1157, 10.1161/CIRCRESAHA.112.269050 Jung, 2009, Circulating endothelial microparticles as a marker of cerebrovascular disease, Ann. Neurol., 66, 191, 10.1002/ana.21681 Lowery-Nordberg, 2011, The effects of high dose interferon-β1a on plasma microparticles: correlation with MRI parameters, J. Neuroinflammation, 8, 43, 10.1186/1742-2094-8-43 Bader, 1998, Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins, Cell, 95, 507, 10.1016/S0092-8674(00)81618-9 Achen, 1995, The non-receptor tyrosine kinase Lyn is localised in the developing murine blood–brain barrier, Differentiation, 59, 15, 10.1046/j.1432-0436.1995.5910015.x Polman, 2011, Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria, Ann. Neurol., 69, 292, 10.1002/ana.22366 Lublin, 1996, Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis, Neurology, 46, 907, 10.1212/WNL.46.4.907 Zivadinov, 2012, Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case–control study, Neuroimage, 59, 331, 10.1016/j.neuroimage.2011.07.045 Zivadinov, 2001, Effects of IV methylprednisolone on brain atrophy in relapsing–remitting MS, Neurology, 57, 1239, 10.1212/WNL.57.7.1239 Batista, 2012, Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis, J. Neurol., 259, 139, 10.1007/s00415-011-6147-1 Patenaude, 2011, A Bayesian model of shape and appearance for subcortical brain segmentation, Neuroimage, 56, 907, 10.1016/j.neuroimage.2011.02.046 Ginat, 2012, Intracranial lesions with high signal intensity on T1-weighted MR images: differential diagnosis, Radiographics, 32, 499, 10.1148/rg.322105761 Balashov, 2011, Acute multiple sclerosis lesion: conversion of restricted diffusion due to vasogenic edema, J. Neuroimaging, 21, 202, 10.1111/j.1552-6569.2009.00443.x Lepore, 2013, Enlargement of cerebral ventricles as an early indicator of encephalomyelitis, PLoS ONE, 8, e72841, 10.1371/journal.pone.0072841 Bartzokis, 1994, In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI, Biol. Psychiatry, 35, 480, 10.1016/0006-3223(94)90047-7 Liem, 2012, 7T MRI reveals diffuse iron deposition in putamen and caudate nucleus in CADASIL, J. Neurol. Neurosurg. Psychiatry, 83, 1180, 10.1136/jnnp-2012-302545 Zivadinov, 2011, Iron deposition and inflammation in multiple sclerosis. Which one comes first?, BMC Neurosci., 12, 60, 10.1186/1471-2202-12-60 Drayer, 1987, Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content?, AJR Am. J. Roentgenol., 149, 357, 10.2214/ajr.149.2.357 Craelius, 1982, Iron deposits surrounding multiple sclerosis plaques, Arch. Pathol. Lab. Med., 106, 397 Adams, 1988, Perivascular iron deposition and other vascular damage in multiple sclerosis, J. Neurol. Neurosurg. Psychiatry, 51, 260, 10.1136/jnnp.51.2.260 Stankiewicz, 2007, Iron in chronic brain disorders: imaging and neurotherapeutic implications, Neurotherapeutics, 4, 371, 10.1016/j.nurt.2007.05.006 LeVine, 1997, Iron deposits in multiple sclerosis and Alzheimer's disease brains, Brain Res., 760, 298, 10.1016/S0006-8993(97)00470-8 Petry, 2007, Magnetic resonance imaging of human brain macrophage infiltration, Neurotherapeutics, 4, 434, 10.1016/j.nurt.2007.05.005 Wakefield, 1994, Immunohistochemical study of vascular injury in acute multiple sclerosis, J. Clin. Pathol., 47, 129, 10.1136/jcp.47.2.129 Al-Radaideh, 2013, Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in clinically isolated syndrome, Mult. Scler., 19, 896, 10.1177/1352458512465135 Williams, 2011, Iron deposition is independent of cellular inflammation in a cerebral model of multiple sclerosis, BMC Neurosci., 12, 59, 10.1186/1471-2202-12-59